SCHEMBL20100779

SCHEMBL20100779

CCc1cc(=O)oc2c1ccc1ccccc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.67
▸ MAPT P10636 4/20 0.53
▸ KDM4E B2RXH2 6/20 0.51
▸ ALDH1A1 P00352 5/20 0.51
▸ PRKDC P78527 2/20 0.51
▸ HPGD P15428 5/20 0.50
▸ HSD17B10 Q99714 2/20 0.48
▸ ALOX15 P16050 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ PDE5A O76074 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ CYP1A1 P04798 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ ABCB1 P08183 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP19A1 P11511 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ CYP2B6 P20813 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17383983 0.86 KMT2A (0.60) KMT2AMAPTKDM4EALDH1A1PRKDC
SCHEMBL12762288 0.80 KMT2A (1.00) KMT2AMAPTKDM4EALDH1A1PRKDC
SCHEMBL12762291 0.80 KMT2A (0.54) KMT2AMAPTKDM4EALDH1A1PRKDC
SCHEMBL15842553 0.80 KDM4E (0.53) MAPTKDM4EALDH1A1HPGDHSD17B10
SCHEMBL14424528 0.80 KMT2A (0.70) KMT2AMAPTKDM4EALDH1A1PRKDC
SCHEMBL12762299 0.79 KMT2A (0.52) KMT2AMAPTKDM4EALDH1A1PRKDC
SCHEMBL2726345 0.78 KMT2A (0.68) KMT2AMAPTKDM4EALDH1A1PRKDC
SCHEMBL17384175 0.78 KMT2A (0.51) KMT2AMAPTKDM4EALDH1A1PRKDC
SCHEMBL2761855 0.77 KMT2A (0.66) KMT2AMAPTKDM4EALDH1A1PRKDC
SCHEMBL16283943 0.77 KMT2A (0.49) KMT2AMAPTKDM4EALDH1A1PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10806733-B2 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation GLOBAL BLOOD THERAPEUTICS, INC. (US) 2020-10-20 — — US disclosed
US-20190160060-A1 SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION GLOBAL BLOOD THERAPEUTICS, INC. 2019-05-30 — — US disclosed
US-10034879-B2 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation GLOBAL BLOOD THERAPEUTICS, INC. (US) 2018-07-31 — — US disclosed
US-20180117040-A1 SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION GLOBAL BLOOD THERAPEUTICS, INC. 2018-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10806733-B2 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation HBB, HBG2, MB KMT2A 1436/4885MAPT 4744/4885KDM4E 863/4885
US-10034879-B2 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation HBB, HBG2, MB KMT2A 1436/4885MAPT 4744/4885KDM4E 863/4885
US-20180117040-A1 SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION HBB, HBG2, MB KMT2A 1436/4885MAPT 4744/4885KDM4E 863/4885
US-20190160060-A1 SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION HBB, HBG2, MB KMT2A 1436/4885MAPT 4744/4885KDM4E 863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback